Finally, a 40-year-old female with perianal Crohn's disease who was systematically receiving anti-tumor necrosis factor (anti-TNF) treatment was the fourth patient; nonetheless, her transphincteric fistulous tract was not responding to medication and required a seton placement. Here, TNF is linked to perianal Crohn disease.